Review Timeline | CrossMark Policy | ClinMed Features
logo
International Journal of

Virology and AIDSISSN: 2469-567X

Archive

 Open Access DOI:10.23937/2469-567X/1510069

Virologic Response among Key Populations Living With HIV following a Switch to Dolutegravir-Based Regimen in Southern Nigeria

Moses Katbi, Adefisayo O Adedoyin, Maryam Bello, Adeoye Adegboye, Oluwatosin Adeoye, Abiye Kalaiwo, Kent Klindera, Iyiola Faturiyele, Tolu Alamu, Homsuk Swomen, Bartholomew Ochonye, Michele Russell, Abdulmalik Abubakar and Babatunji Odelola

Article Type: Original Research | First Published: September 05, 2020

Achieving optimal virologic suppression among key population groups is essential to HIV epidemic control. The recommendation to transition HIV positive key populations from efavirenz-based regimen (Tenofovir, Lamivudine, Efavirenz (TLE)) to dolutegravir-based regimen (Tenofovir, Lamivudine, Dolutegravir (TLD)) considered the effectiveness of dolutegravir in achieving suppressed viral loads within a short period of time. The aim of this study was to investigate the virologic outcome of key popula...

 Open Access DOI:10.23937/2469-567X/1510068

Closing the Gap in Pediatric HIV Case Finding: A Review of the PASS Strategy in Southern Nigeria

Moses Katbi, Doreen Magaji, Tessie Philips-Ononye, Emnet Aberra, Maryam Bello, Adefisayo Adedoyin, Rebecca Carthcart, Adeoye Adegboye, Abiye Kalaiwo, Angela Agweye, Akinyemi Atobatele, Abdulmalik Abubakar, Homsuk Swomen, Temitayo Odusote, Onyeka Igboelina and Michele Russell

Article Type: Original Research | First Published: August 24, 2020

Achieving optimal treatment for all groups of individuals living with HIV is essential to attaining epidemic control. About 191,395 children and adolescents under 19 are living with HIV (C/ALHIV) with only 46,461 (24%) on treatment in Nigeria. In order to close this treatment gap, the pediatric ART saturation strategy (PASS), was developed between care and treatment team and orphans and vulnerable children (OVC) team to ensure identification and treatment of C/ALHIV and return of children who we...

Volume 7
Issue 2